辅助肝移植伴延迟全肝切除术:遵循ALPPS原则从2期APOLT到快速的演变。

IF 5 2区 医学 Q1 IMMUNOLOGY
Shuai Wu, Guangyao Li, Bo Zhou, Shiran Zhang, Geng Chen
{"title":"辅助肝移植伴延迟全肝切除术:遵循ALPPS原则从2期APOLT到快速的演变。","authors":"Shuai Wu, Guangyao Li, Bo Zhou, Shiran Zhang, Geng Chen","doi":"10.1097/TP.0000000000005501","DOIUrl":null,"url":null,"abstract":"<p><p>The resection and partial liver segment 2/3 transplantation with delayed total hepatectomy (RAPID) represents an innovative fusion of 2 of the most challenging procedures of modern liver surgery: auxiliary partial orthotopic liver transplantation and associating liver partition and portal vein ligation for staged hepatectomy. By combining the principles of auxiliary partial orthotopic liver transplantation of partial graft implantation with staged parenchymal modulation of associating liver partition and portal vein ligation for staged hepatectomy, RAPID enables sequential hypertrophy of the transplanted graft followed by complete native liver removal, addressing critical limitations in donor-recipient size matching. Current evidence highlights its primary application in treating unresectable hepatic malignancies, demonstrating advantages over conventional strategies in preserving functional liver volume, minimizing the risk of small-for-size syndrome, and accelerating graft regeneration. However, the procedure faces unresolved challenges, including ethical debates over living donor utilization in oncological contexts, necessity and feasibility of portal inflow modulation, optimal timing for delayed hepatectomy, insufficient long-term oncological outcome data and so on. This review provides an overview of the past and current status of RAPID, especially with respect to its evolution, indication, and technical details, as well as the potential challenges that have been discussed. Additionally, future directions of this surgical paradigm are outlined.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Auxiliary Liver Transplantation With Delayed Total Hepatectomy: Evolution From 2-stage APOLT to RAPID Following the ALPPS Principles.\",\"authors\":\"Shuai Wu, Guangyao Li, Bo Zhou, Shiran Zhang, Geng Chen\",\"doi\":\"10.1097/TP.0000000000005501\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The resection and partial liver segment 2/3 transplantation with delayed total hepatectomy (RAPID) represents an innovative fusion of 2 of the most challenging procedures of modern liver surgery: auxiliary partial orthotopic liver transplantation and associating liver partition and portal vein ligation for staged hepatectomy. By combining the principles of auxiliary partial orthotopic liver transplantation of partial graft implantation with staged parenchymal modulation of associating liver partition and portal vein ligation for staged hepatectomy, RAPID enables sequential hypertrophy of the transplanted graft followed by complete native liver removal, addressing critical limitations in donor-recipient size matching. Current evidence highlights its primary application in treating unresectable hepatic malignancies, demonstrating advantages over conventional strategies in preserving functional liver volume, minimizing the risk of small-for-size syndrome, and accelerating graft regeneration. However, the procedure faces unresolved challenges, including ethical debates over living donor utilization in oncological contexts, necessity and feasibility of portal inflow modulation, optimal timing for delayed hepatectomy, insufficient long-term oncological outcome data and so on. This review provides an overview of the past and current status of RAPID, especially with respect to its evolution, indication, and technical details, as well as the potential challenges that have been discussed. Additionally, future directions of this surgical paradigm are outlined.</p>\",\"PeriodicalId\":23316,\"journal\":{\"name\":\"Transplantation\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/TP.0000000000005501\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/TP.0000000000005501","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

延迟全肝切除术(RAPID)的切除和部分肝段2/3移植代表了现代肝脏手术中最具挑战性的两种手术的创新融合:辅助部分原位肝移植和分阶段肝切除术的肝分区和门静脉结扎。通过将部分移植物植入的辅助部分原位肝移植与分阶段肝分区的相关实质调节和门静脉结扎的分阶段肝切除术的原理相结合,RAPID实现了移植移植物的顺序肥厚,然后是完全的天然肝切除,解决了供体-受体大小匹配的关键限制。目前的证据强调其主要应用于治疗不可切除的肝脏恶性肿瘤,在保留功能肝体积、最小化小尺寸综合征风险和加速移植物再生方面优于传统策略。然而,该程序面临着尚未解决的挑战,包括关于肿瘤环境下活体供体使用的伦理争论,门脉流入调节的必要性和可行性,延迟肝切除术的最佳时机,长期肿瘤结果数据不足等。这篇综述概述了RAPID的过去和现在的状况,特别是关于它的发展、适应症和技术细节,以及已经讨论过的潜在挑战。此外,还概述了该手术模式的未来发展方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Auxiliary Liver Transplantation With Delayed Total Hepatectomy: Evolution From 2-stage APOLT to RAPID Following the ALPPS Principles.

The resection and partial liver segment 2/3 transplantation with delayed total hepatectomy (RAPID) represents an innovative fusion of 2 of the most challenging procedures of modern liver surgery: auxiliary partial orthotopic liver transplantation and associating liver partition and portal vein ligation for staged hepatectomy. By combining the principles of auxiliary partial orthotopic liver transplantation of partial graft implantation with staged parenchymal modulation of associating liver partition and portal vein ligation for staged hepatectomy, RAPID enables sequential hypertrophy of the transplanted graft followed by complete native liver removal, addressing critical limitations in donor-recipient size matching. Current evidence highlights its primary application in treating unresectable hepatic malignancies, demonstrating advantages over conventional strategies in preserving functional liver volume, minimizing the risk of small-for-size syndrome, and accelerating graft regeneration. However, the procedure faces unresolved challenges, including ethical debates over living donor utilization in oncological contexts, necessity and feasibility of portal inflow modulation, optimal timing for delayed hepatectomy, insufficient long-term oncological outcome data and so on. This review provides an overview of the past and current status of RAPID, especially with respect to its evolution, indication, and technical details, as well as the potential challenges that have been discussed. Additionally, future directions of this surgical paradigm are outlined.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Transplantation
Transplantation 医学-免疫学
CiteScore
8.50
自引率
11.30%
发文量
1906
审稿时长
1 months
期刊介绍: The official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations per year. Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation for over 50 years. The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal. Transplantation is committed to rapid review and publication. The journal remains competitive with a time to first decision of fewer than 21 days. Transplantation was the first in the field to offer CME credit to its peer reviewers for reviews completed. The journal publishes original research articles in original clinical science and original basic science. Short reports bring attention to research at the forefront of the field. Other areas covered include cell therapy and islet transplantation, immunobiology and genomics, and xenotransplantation. ​
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信